Michael Zinda - Mar 12, 2025 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role
EVP, CHIEF SCIENTIFIC OFFICER
Signature
/s/ Steve Forte, Attorney-in-Fact
Stock symbol
RPTX
Transactions as of
Mar 12, 2025
Transactions value $
-$6,397
Form type
4
Date filed
3/14/2025, 04:30 PM
Previous filing
Mar 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPTX Common Shares Sale -$6.4K -5.61K -6.53% $1.14 80.3K Mar 12, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represent shares sold to satisfy the Reporting Person's tax withholding obligation in connection with the vesting and settlement of restricted stock units and does not represent a discretionary sale by the holder.